Cargando…

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma

Ferroptosis is a novel form of cell death and plays a role in various diseases, especially tumors. It has been reported that ferroptosis is involved in the growth and progression of clear cell renal cell carcinoma (ccRCC); however, the specific molecular mechanisms are still unclear. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Su, Ruan, Hailong, Liu, Jingchong, Liu, Yuenan, Liu, Di, Tong, Junwei, Shi, Jian, Yang, Hongmei, Xu, Tianbo, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336466/
https://www.ncbi.nlm.nih.gov/pubmed/34367965
http://dx.doi.org/10.3389/fonc.2021.678694
_version_ 1783733324834930688
author Gao, Su
Ruan, Hailong
Liu, Jingchong
Liu, Yuenan
Liu, Di
Tong, Junwei
Shi, Jian
Yang, Hongmei
Xu, Tianbo
Zhang, Xiaoping
author_facet Gao, Su
Ruan, Hailong
Liu, Jingchong
Liu, Yuenan
Liu, Di
Tong, Junwei
Shi, Jian
Yang, Hongmei
Xu, Tianbo
Zhang, Xiaoping
author_sort Gao, Su
collection PubMed
description Ferroptosis is a novel form of cell death and plays a role in various diseases, especially tumors. It has been reported that ferroptosis is involved in the growth and progression of clear cell renal cell carcinoma (ccRCC); however, the specific molecular mechanisms are still unclear. In this study, we constructed a four-gene signature (FeSig) of ferroptosis-related genes via Cox regression analysis. ROC and survival analyses indicated that FeSig had good diagnostic and prognostic value. Further analysis revealed that ferroptosis was associated with tumor immunity in ccRCC. Next, weighted gene co-expression network analysis was performed to identify the potential regulatory mechanisms. Combined with correlation and survival analyses, the TAZ/WNT10B axis was identified as a tumor immune-related regulatory pathway. In conclusion, these findings suggest that ferroptosis is correlated with tumor immunity. The TAZ/WNT10B axis may be a novel biomarker and therapeutic target for immunotherapy in ccRCC.
format Online
Article
Text
id pubmed-8336466
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83364662021-08-05 A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma Gao, Su Ruan, Hailong Liu, Jingchong Liu, Yuenan Liu, Di Tong, Junwei Shi, Jian Yang, Hongmei Xu, Tianbo Zhang, Xiaoping Front Oncol Oncology Ferroptosis is a novel form of cell death and plays a role in various diseases, especially tumors. It has been reported that ferroptosis is involved in the growth and progression of clear cell renal cell carcinoma (ccRCC); however, the specific molecular mechanisms are still unclear. In this study, we constructed a four-gene signature (FeSig) of ferroptosis-related genes via Cox regression analysis. ROC and survival analyses indicated that FeSig had good diagnostic and prognostic value. Further analysis revealed that ferroptosis was associated with tumor immunity in ccRCC. Next, weighted gene co-expression network analysis was performed to identify the potential regulatory mechanisms. Combined with correlation and survival analyses, the TAZ/WNT10B axis was identified as a tumor immune-related regulatory pathway. In conclusion, these findings suggest that ferroptosis is correlated with tumor immunity. The TAZ/WNT10B axis may be a novel biomarker and therapeutic target for immunotherapy in ccRCC. Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8336466/ /pubmed/34367965 http://dx.doi.org/10.3389/fonc.2021.678694 Text en Copyright © 2021 Gao, Ruan, Liu, Liu, Liu, Tong, Shi, Yang, Xu and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gao, Su
Ruan, Hailong
Liu, Jingchong
Liu, Yuenan
Liu, Di
Tong, Junwei
Shi, Jian
Yang, Hongmei
Xu, Tianbo
Zhang, Xiaoping
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
title A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
title_full A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
title_fullStr A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
title_full_unstemmed A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
title_short A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
title_sort novel ferroptosis-related pathway for regulating immune checkpoints in clear cell renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336466/
https://www.ncbi.nlm.nih.gov/pubmed/34367965
http://dx.doi.org/10.3389/fonc.2021.678694
work_keys_str_mv AT gaosu anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT ruanhailong anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT liujingchong anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT liuyuenan anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT liudi anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT tongjunwei anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT shijian anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT yanghongmei anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT xutianbo anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT zhangxiaoping anovelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT gaosu novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT ruanhailong novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT liujingchong novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT liuyuenan novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT liudi novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT tongjunwei novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT shijian novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT yanghongmei novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT xutianbo novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma
AT zhangxiaoping novelferroptosisrelatedpathwayforregulatingimmunecheckpointsinclearcellrenalcellcarcinoma